TLI

Thought Leadership & Innovation Foundation Chairman and President, Bill Oldham Featured on One World Initiative Public Broadcast: Innovation Improves Access to Healthcare, Improves Outcomes

Retrieved on: 
Mardi, mai 14, 2024
Software, Research, Managed Care, Pharmaceutical, Telemedicine, Virtual Medicine, Data Management, Technology, Health Technology, Clinical Trials, Science, Practice Management, Health, Knowledge, Clinical professor, Partnership, Amputation, Patient, Bangladesh Technical Education Board, Mayo Clinic, Macular degeneration, Interview, National Institutes of Health, Public policy, Conditional sentence, OWI, Public, Mental health, TLI, Artificial intelligence, Telehealth, NIH, Pharmaceutical industry

A nonprofit global public broadcast organization, OWI increases cooperation worldwide through broadcast programming, integrated media, printed materials and international events.

Key Points: 
  • A nonprofit global public broadcast organization, OWI increases cooperation worldwide through broadcast programming, integrated media, printed materials and international events.
  • “Access to quality healthcare is a fundamental human right, and TLI is dedicated to driving innovation to ensure that everyone, regardless of their background or circumstances, has access to the care they need.
  • He also highlights the importance of telemedicine and patient portals in making healthcare more accessible and convenient for patients.
  • “I am extremely optimistic about the future of healthcare and growing awareness of the importance of nutrition, activity and mental health,” he shares.

The Lundquist Institute Receives $2.6 Million Grant from U.S. Army Medical Research Acquisition Activity to Develop Wearable Biosensors

Retrieved on: 
Jeudi, avril 25, 2024
UCLA, Mortality, Patient, Lower respiratory tract infection, Blood, Health, CRP, Death, Partnership, Doctor of Philosophy, Research, COPD, TLI, Electronics, Conditional sentence, AECOPD, Hospital, Perspiration, Infection, Disease, Chronic obstructive pulmonary disease, Pharmaceutical industry

Torrance, California, April 24, 2024 (GLOBE NEWSWIRE) -- The U.S. Army Medical Research Acquisition Activity (USAMRAA) has awarded The Lundquist Institute (TLI) a four-year grant totaling $2,623,234.

Key Points: 
  • Torrance, California, April 24, 2024 (GLOBE NEWSWIRE) -- The U.S. Army Medical Research Acquisition Activity (USAMRAA) has awarded The Lundquist Institute (TLI) a four-year grant totaling $2,623,234.
  • The research project is led by Dr. Harry Rossiter, an investigator at TLI and Professor at the David Geffen School of Medicine at UCLA.
  • The project aims to develop wearable multiplex biosensors to monitor exacerbation risk in chronic obstructive pulmonary disease (COPD).
  • COPD affects approximately 16 million Americans and is the third leading cause of death globally.

Lundquist Investigator Dr. Yoshihara Awarded $3 Million NIH R01 Grant for Diabetes Stem Cell Therapy Research

Retrieved on: 
Lundi, avril 1, 2024
TLI, Diabetes, Immunosuppression, Type 1, Research, Kidney, Hope, Doctor of Philosophy, NIH, Type 1 diabetes, NIDDK, Bangladesh Technical Education Board, UCLA, Digestive, Health, Cell, Organoid, Type 2, Medical device

This prestigious NIH R01 grant, known for its rigorous peer-review process, is dedicated to advancing stem cell therapy research for treating diabetes.

Key Points: 
  • This prestigious NIH R01 grant, known for its rigorous peer-review process, is dedicated to advancing stem cell therapy research for treating diabetes.
  • Insulin-dependent diabetes, including autoimmune Type 1 and stress-induced Type 2, presents a significant health burden, often necessitating lifelong insulin therapy and glucose monitoring.
  • Dr. Yoshihara's research focuses on the potential of human pluripotent stem cells (hPSCs) to create functional islet cells.
  • “Despite significant progress in stem cell-derived mini-organ technologies, we are still challenged by their functional immaturity and variability,” said Dr. Yoshihara.

TLI Investigator Dr. Nicholas Jenzjowsky Receives NIH/NIAID Grant to Investigate the Neural Regulation of Asthma

Retrieved on: 
Mercredi, mars 20, 2024
TLI, Asthma, Research, Hope, Doctor of Philosophy, Allergy, Neuron, Immunoglobulin E, Infection, Pharmaceutical industry

The grant will fund the innovative project "Asthmatic inflammation requires neuronal upregulation of B-cells," which commenced this month and will run until January 2025.

Key Points: 
  • The grant will fund the innovative project "Asthmatic inflammation requires neuronal upregulation of B-cells," which commenced this month and will run until January 2025.
  • This groundbreaking research aims to delve into the complexities of asthma and its symptoms, a major global health concern that requires a deeper understanding of its underlying mechanisms.
  • The innovative nature of this project underscores TLI's commitment to cutting-edge science and the potential impact of the research.
  • It aims to uncover potential drug targets and inform new strategies to mitigate the growing problem of allergic asthma.

Lundquist Institute Investigator Dr. Loren Miller to Receive 2024 Top Ten Clinical Research Achievement Award from the Clinical Research Forum

Retrieved on: 
Jeudi, février 15, 2024
Infection, Human services, Chlorhexidine, Paris Las Vegas, University of California, Irvine, Nursing, TLI, Harbor–UCLA Medical Center, Physiology, Agency, Conference, Disease, Interim, Health, Tufts University, University, UC, MPH, Clinical trial, Diagnosis, Science, UCLA, Nose, Pharmaceutical industry

Los Angeles, California, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) is pleased to announce that Lundquist Investigator Loren Miller, MD, MPH will be honored with a 2024 Top Ten Clinical Research Achievement Award

Key Points: 
  • Los Angeles, California, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) is pleased to announce that Lundquist Investigator Loren Miller, MD, MPH will be honored with a 2024 Top Ten Clinical Research Achievement Award
    by the Clinical Research Forum (CR Forum) at a ceremony in Las Vegas, NV on April 2, 2024.
  • The Top 10 Clinical Research Achievement Awards honor groundbreaking achievements in clinical research nationwide.
  • The award recognizes the Protect Trial, a clinical trial jointly led by Dr. Miller and senior investigator Susan Huang, MD, MPH, Chancellor’s Professor at the University of California, Irvine.
  • “I am pleased to congratulate Dr. Loren Miller on receiving this prestigious award from the Clinical Research Forum,” said Dr. Marianne Gausche-Hill, Interim President and CEO of The Lundquist Institute.

Thought Leadership & Innovation Foundation Announces Strategic Partnership with American Macular Degeneration Foundation, Debuts Patient Testimonial Video Featuring TLI Fellow

Retrieved on: 
Lundi, février 5, 2024
Research, Women, Seniors, Genetics, Men, Health, Consumer, Optical, Science, Partnership, Public, Macular degeneration, Obesity, AMD, Ageing, Diagnosis, Risk factor, Retina, TLI, Risk, Smoking, Eye, Pharmaceutical industry

Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and public health, today announces a strategic partnership with the American Macular Degeneration Foundation (AMDF), beginning with the debut of a patient testimonial video produced by the AMDF and featuring TLI Fellow, Laura Carabello, who documents her timely intervention and management of macular degeneration.

Key Points: 
  • Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and public health, today announces a strategic partnership with the American Macular Degeneration Foundation (AMDF), beginning with the debut of a patient testimonial video produced by the AMDF and featuring TLI Fellow, Laura Carabello, who documents her timely intervention and management of macular degeneration.
  • As a patient advocate for AMDF and as Chair of the TLI Fellows, Carabello urges people to understand their risk for macular degeneration, recognize symptoms, seek early treatment and be compliant with ongoing therapy.
  • “Laura's journey provides an insightful and assuring perspective, chronicling her personal challenges with macular degeneration from diagnosis to clinical intervention.
  • Together, TLI and AMDF are dedicated to advancing awareness, research and support, forging a path towards a future where the impact of macular degeneration is minimized, and the gift of sight is preserved.

Tetra Laval International Digital Transformation Strategy Analysis Report 2023: Packaging Activities, Innovation Programs, Technology Initiatives, Estimated ICT Budget, and Major ICT Contracts

Retrieved on: 
Lundi, février 5, 2024
Tetra, Robotics, DeLaval, Milk, Research, AI, 3D, Tetra Pak, Food, Sidel, Investment, Agility, Hexagon, TLI, Acquisition, Industrial internet of things, Fourth Industrial Revolution, Data science, Ideation, Engineering, ICT

DUBLIN, Feb. 5, 2024 /PRNewswire/ -- The "Tetra Laval International SA - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 5, 2024 /PRNewswire/ -- The "Tetra Laval International SA - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering.
  • This report provides insight into Tetra Laval International SA (TLI) packaging activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its estimated ICT budget, and its major ICT contracts.
  • Tetra Laval International SA (TLI) is a provider of packaging solutions.
  • TLI operates through the companies Tetra Pak, Sidel and DeLaval, which carries out the development of technologies for the packaging and distribution of food.

Tianli Education: Leading China's Educational Innovation with AI

Retrieved on: 
Mercredi, janvier 31, 2024
Learning, Education, Multimedia, Artificial intelligence, Teaching, Algorithm, Curriculum, Student, Job satisfaction, TLI, Cloud computing, AI, Tutoring

HONG KONG, Jan. 30, 2024 /PRNewswire/ -- In the wave of innovation sweeping through China's educational sector, Tianli Education, a brand of Tianli International Holdings Limited, is at the forefront, revolutionizing traditional education paradigms with its significant advancements in AI and smart education.

Key Points: 
  • HONG KONG, Jan. 30, 2024 /PRNewswire/ -- In the wave of innovation sweeping through China's educational sector, Tianli Education, a brand of Tianli International Holdings Limited, is at the forefront, revolutionizing traditional education paradigms with its significant advancements in AI and smart education.
  • Notably, this platform extends its services beyond the confines of Tianli Education, aiming to bring revolutionary changes to the national and even global educational landscape.
  • To vividly demonstrate Tianli Education's achievements in AI and smart education, let's consider specific data and examples.
  • On this foundation, the educational models and philosophies of Tianli Education are set to become a banner leading the future of global education.

Sands Point Risk Launches Managing General Agent Platform with Flagship Transaction Liability Insurance Practice

Retrieved on: 
Mardi, janvier 23, 2024
Transaction, Policy, Insurance, Executive, Representation, DUAL, Contingency, TLI

JERSEY CITY, N.J., Jan. 23, 2024 (GLOBE NEWSWIRE) -- An underwriting team that is widely recognized as leaders in the Transaction Liability Insurance (“TLI”) industry is pleased to announce the launch of Sands Point Risk (“Sands Point'' or “the Company”).

Key Points: 
  • JERSEY CITY, N.J., Jan. 23, 2024 (GLOBE NEWSWIRE) -- An underwriting team that is widely recognized as leaders in the Transaction Liability Insurance (“TLI”) industry is pleased to announce the launch of Sands Point Risk (“Sands Point'' or “the Company”).
  • Sands Point is a managing general agent (“MGA”) focused on supporting expanded opportunities across financial and property and casualty insurance lines.
  • With its flagship TLI practice, Sands Point will offer a full suite of products in TLI, including Representation and Warranties, Tax Liability and Contingent Liability Insurance.
  • We will also be looking for opportunities to deliver this same level of best-in-class underwriting and customer service in other specialized insurance lines as we build out the Sands Point platform.”

Thought Leadership & Innovation Foundation (TLI) Welcomes Esteemed Fellows to Advance Global Healthcare Innovation

Retrieved on: 
Mercredi, décembre 13, 2023
Diabetes, Data Management, Other Health, Technology, Practice Management, Physical Therapy, Managed Care, Medical Devices, Fitness & Nutrition, Clinical Trials, Science, Alternative Medicine, Other Science, Health, Medical Supplies, Patient, Hope, TLI, Partnership, Management, Renewable energy

The Foundation pursues its mission to foster transformative changes that inspire hope for patients and families confronting challenging health conditions.

Key Points: 
  • The Foundation pursues its mission to foster transformative changes that inspire hope for patients and families confronting challenging health conditions.
  • TLI's core values, encompassing innovation, integrity, partnership, impartiality, intellectual curiosity and excellence, drive its efforts to integrate science, technology and strategic thinking for the public benefit.
  • Murphy continues, "These distinguished Fellows bring extensive experience, profound expertise and unwavering dedication to advancing healthcare.
  • Together, we are determined to harness the power of thought leadership and innovation to address the most pressing health challenges of our time."